September 8th, 2010
U.S. CABG Centers Rated
Physician's First Watch, CardioExchange Staff
Consumer Reports published ratings for 221 CABG centers in the U.S. on Tuesday.
The ratings, based on data collected by the Society of Thoracic Surgeons, take into account 11 performance measures — for example, postoperative renal failure, operative mortality, and surgical re-exploration.
All centers included in the report volunteered to have their data made public. A New England Journal of Medicine perspective calls such reporting “a watershed event in health care accountability.”
This post is reprinted from Physician’s First Watch, a part of the Journal Watch family. PFW is a free daily alert on current news that affects your practice — from medical journals, government agencies, scientific conferences, and major media reports.
—
Categories: Cardiac Surgery
Tags: CABG, ratings
You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.
Search the Archive
Archives by Date
NEJM — Recent Cardiology Articles- Thromboprophylaxis for Atrial Fibrillation in Patients with Drug-Eluting Stents February 12, 2026Stroke prevention is one of the pillars of treatment for patients with atrial fibrillation, and oral anticoagulation with a direct oral anticoagulant (DOAC) is now the preferred option for thromboprophylaxis.1 Nevertheless, patients with atrial fibrillation commonly have coexistent vascular disease, so they may present with an acute...
- Adenoviral Inciting Antigen and Somatic Hypermutation in VITT February 12, 2026VITT is caused by a somatic hypermutation of an anti–adenovirus pVII antibody that generates more avid binding of platelet factor 4 than of adenovirus pVII, its original target, which results in platelet activation.
- Case 5-2026: An 18-Year-Old Woman with Headache and Hypertension February 12, 2026An 18-year-old woman with chronic headaches was admitted to the pediatric intensive care unit for a hypertensive emergency. The potassium level was 2.0 mmol per liter. A diagnosis was made.
- Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents February 12, 2026In patients with atrial fibrillation and a drug-eluting stent placed at least 1 year earlier, monotherapy with a non–vitamin K antagonist oral anticoagulant was noninferior to combination therapy with clopidogrel for net adverse clinical events.
- LVAD February 5, 2026When a man ends up in the ED after having severed the driveline of his left ventricular assist device, the medical student on his team learns that sometimes a life saved is not the life the patient wants to live.
- Thromboprophylaxis for Atrial Fibrillation in Patients with Drug-Eluting Stents February 12, 2026
-
Tag Cloud
- ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
